Abstract
Oligophrenin-1 (OPHN1) encodes for a Rho-GTPase-activating protein, important for dendritic morphogenesis and synaptic function. Mutations in this gene have been identified in patients with X-linked intellectual disability associated with cerebellar hypoplasia. ADAR enzymes are responsible for A-to-I RNA editing, an essential post-transcriptional RNA modification contributing to transcriptome and proteome diversification. Specifically, ADAR2 activity is essential for brain development and function. Herein, we show that the OPHN1 transcript undergoes post-transcriptional modifications such as A-to-I RNA editing and alternative splicing in human brain and other tissues. We found that OPHN1 editing is detectable already at the 18th week of gestation in human brain with a boost of editing at weeks 20 to 33, concomitantly with OPHN1 expression increase and the appearance of a novel OPHN1 splicing isoform. Our results demonstrate that multiple post-transcriptional events occur on OPHN1, a gene playing an important role in brain function and development.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenosine Deaminase / metabolism
-
Alternative Splicing*
-
Base Sequence
-
Brain / embryology
-
Brain / metabolism*
-
Cell Line
-
Cytoskeletal Proteins / genetics*
-
GTPase-Activating Proteins / genetics*
-
Gene Expression Regulation, Developmental
-
Gene Order
-
Humans
-
Mental Retardation, X-Linked / embryology
-
Mental Retardation, X-Linked / genetics*
-
Mental Retardation, X-Linked / metabolism
-
Molecular Sequence Data
-
Nuclear Proteins / genetics*
-
Nucleic Acid Conformation
-
Organogenesis / genetics*
-
RNA Editing*
-
RNA Isoforms
-
RNA Precursors / chemistry
-
RNA Precursors / genetics
-
RNA-Binding Proteins / metabolism
Substances
-
Cytoskeletal Proteins
-
GTPase-Activating Proteins
-
Nuclear Proteins
-
OPHN1 protein, human
-
RNA Isoforms
-
RNA Precursors
-
RNA-Binding Proteins
-
ADARB1 protein, human
-
Adenosine Deaminase
Grants and funding
This work was supported by an IG grant (n. 13202) to A.G. from AIRC (Associazione Italiana Ricerca sul cancro) and by the special project 5×1000 AIRC to F.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.